Dattatray Pawar
Overview
Explore the profile of Dattatray Pawar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tiwaskar M, Charde S, Balankhe N, Hegde A, Deodhar M, Gondane A, et al.
J Assoc Physicians India
. 2025 Mar;
73(3):e22-e28.
PMID: 40087939
Nimesulide, a potent nonsteroidal anti-inflammatory drug (NSAID), has garnered attention for its distinct mechanism of action, characterized by its selective inhibition of cyclooxygenase-2 (COX-2) and multifaceted pharmacological properties. Extensive clinical...
2.
Paul T, Garg B, Kapoor N, Patil V, Kachnerkar N, Shembalkar J, et al.
J Assoc Physicians India
. 2025 Feb;
73(1):e8-e13.
PMID: 39893524
Objective: Denosumab, a human monoclonal antibody that exhibits strong affinity and specificity for the receptor activator of nuclear factor-kappa B ligand (RANK-L), is essential in regulating bone turnover. Its inhibition...
3.
Rana P, Deshmukh H, Shah U, Kumar V, Kanungo S, Singhal D, et al.
Clin Ophthalmol
. 2024 Nov;
18:3071-3081.
PMID: 39493839
Objective: This study aimed to compare efficacy, safety, and immunogenicity of the biosimilar ranibizumab in comparison with the Innovator Ranibizumab in treatment-naive patients with neovascular (wet) age-related macular degeneration (nAMD...
4.
Sharma B, Chalikwar R, Bhalerao S, Gondane A, Pawar D, Sharma A
Cureus
. 2024 Oct;
16(9):e69146.
PMID: 39398799
Cefotaxime and ceftriaxone are two prominent third-generation cephalosporin antibiotics, which are a class of antimicrobial agents with overlapping antibacterial spectra and therapeutic indications, commonly used in treating severe bacterial infections,...
5.
Jena D, Ghosh T, Pal A, Pawar D, Sharma A
Cureus
. 2024 Aug;
16(7):e64717.
PMID: 39156307
Amoxicillin/clavulanate (co-amoxiclav) is a widely used antibiotic in community healthcare settings, combining amoxicillin and clavulanate potassium to combat β-lactamase-producing bacteria. Despite its extensive use, limited pharmacokinetic/pharmacodynamic data support current dosing...
6.
Choudhary R, Khan M, Dosi R, Choudhari S, Pawar D, Shahavi V, et al.
Indian Heart J
. 2024 Jul;
76(4):280-285.
PMID: 39009075
Objective: To compare the efficacy and safety of a fixed-dose combination of aspirin and pantoprazole with that of aspirin alone for the prevention of gastro duodenal mucosal damage in patients...
7.
Patil S, Nadaf N, Gupta S, Barai P, Makhija S, Lodha P, et al.
Cureus
. 2024 May;
16(4):e58859.
PMID: 38800230
Objective In this study, we aimed to compare the efficacy and safety of the fixed-dose combination (FDC) of nimesulide (100 mg) + paracetamol (325 mg) [NP], ketorolac (10 mg) [Kt]...
8.
Tiwaskar M, Vora A, Saraf A, Bhadade R, Choudhari S, Pawar D, et al.
J Assoc Physicians India
. 2024 May;
72(3):66-72.
PMID: 38736120
Antibiotics are the magic bullets that have saved millions worldwide. Enormous and irresponsible use of antibiotics has led to resistance to antibiotics, which is a matter of global health concern....
9.
Bhatnagar M, Choudhari S, Pawar D, Sharma A
Cureus
. 2024 Feb;
16(1):e52773.
PMID: 38389608
Globally, over 25% of the population suffers from acid-related disorders such as dyspepsia or gastroesophageal reflux disease (GERD), and around 7.6% of Indians report having GERD symptoms on a frequent...
10.
Sanghavi S, Ghoshal U, Poddar S, Satpute M, Sahu C, Pawar D, et al.
Cureus
. 2023 Oct;
15(9):e46014.
PMID: 37900428
Background This study was designed to evaluate the current in vitro susceptibility of clinical isolates to broad-spectrum β-lactam antibiotics. Methodology Bacterial isolates, cultured from 180 non-repetitive clinical samples between April...